Companies › ENLV

ENLIVEX LTD COM (ENLV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001596812 · EDGAR filings · Updated 2026-07-28

ENLIVEX LTD COM (ENLV) has reported institutional ownership of 1.5%, with 35 institutional managers holding positions valued at $3.38M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-28 — Foreign issuer report (6-K) filed
• 2026-07-28 — Foreign issuer report (6-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-20 — Foreign issuer report (6-K) filed
• 2026-07-13 — Foreign issuer report (6-K) filed
• 2026-07-07 — Foreign issuer report (6-K) filed
• 2026-06-24 — Foreign issuer report (6-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENLIVEX LTD COM has 35 institutional holders and institutional ownership of 1.5%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

BRIACELL THERAPEUTICS CORP (BCTX) · TIZIANA LIFE SCIENCES LTD (TLSA) · Rockwell Medical Inc (RMTI) · GREENLAND MINES LTD (GRML) · PDS BIOTECHNOLOGY CORP (PDSB) · IRIDEX CORP (IRIX)